Literature DB >> 23570887

Involvement of brain-derived neurotrophic factor in late-life depression.

Yogesh Dwivedi1.   

Abstract

Brain-derived neurotrophic factor (BDNF), one of the major neurotrophic factors, plays an important role in the maintenance and survival of neurons, synaptic integrity, and synaptic plasticity. Evidence suggests that BDNF is involved in major depression, such that the level of BDNF is decreased in depressed patients and that antidepressants reverse this decrease. Stress, a major factor in depression, also modulates BDNF expression. These studies have led to the proposal of the neurotrophin hypothesis of depression. Late-life depression is associated with disturbances in structural and neural plasticity as well as impairments in cognitive behavior. Stress and aging also play a crucial role in late-life depression. Many recent studies have suggested that not only expression of BDNF is decreased in the serum/plasma of patients with late-life depression, but structural abnormalities in the brain of these patients may be associated with a polymorphism in the BDNF gene, and that there is a relationship between a BDNF polymorphism and antidepressant remission rates. This review provides a critical review of the involvement of BDNF in major depression, in general, and in late-life depression, in particular.
Copyright © 2013 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23570887      PMCID: PMC3767381          DOI: 10.1016/j.jagp.2012.10.026

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  196 in total

1.  Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.

Authors:  Luisella Bocchio-Chiavetto; Roberta Zanardini; Marco Bortolomasi; Maria Abate; Matilde Segala; Mario Giacopuzzi; Marco Andrea Riva; Eleonora Marchina; Patrizio Pasqualetti; Jorge Perez; Massimo Gennarelli
Journal:  Eur Neuropsychopharmacol       Date:  2006-06-06       Impact factor: 4.600

2.  Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.

Authors:  Brian A Hoshaw; Jessica E Malberg; Irwin Lucki
Journal:  Brain Res       Date:  2005-03-10       Impact factor: 3.252

3.  Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment.

Authors:  Haobo Zhang; Julian N Trollor; Wei Wen; Wanlin Zhu; John D Crawford; Nicole A Kochan; Melissa J Slavin; Henry Brodaty; Simone Reppermund; Kristan Kang; Karen A Mather; Perminder S Sachdev
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-11-03       Impact factor: 10.154

4.  Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan.

Authors:  T B Romanczyk; C Shannon Weickert; M J Webster; M M Herman; M Akil; J E Kleinman
Journal:  Eur J Neurosci       Date:  2002-01       Impact factor: 3.386

5.  Social support and the outcome of major depression.

Authors:  L K George; D G Blazer; D C Hughes; N Fowler
Journal:  Br J Psychiatry       Date:  1989-04       Impact factor: 9.319

6.  Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings.

Authors:  G Rosoklija; G Toomayan; S P Ellis; J Keilp; J J Mann; N Latov; A P Hays; A J Dwork
Journal:  Arch Gen Psychiatry       Date:  2000-04

7.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

8.  Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.

Authors:  F Miyajima; W Ollier; A Mayes; A Jackson; N Thacker; P Rabbitt; N Pendleton; M Horan; A Payton
Journal:  Genes Brain Behav       Date:  2007-10-31       Impact factor: 3.449

Review 9.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

10.  Rapid and selective induction of BDNF expression in the hippocampus during contextual learning.

Authors:  J Hall; K L Thomas; B J Everitt
Journal:  Nat Neurosci       Date:  2000-06       Impact factor: 24.884

View more
  20 in total

1.  Dysregulation of the SNARE-binding protein Munc18-1 impairs BDNF secretion and synaptic neurotransmission: a novel interventional target to protect the aging brain.

Authors:  Young Il Lee; Yun Gi Kim; Hee Jang Pyeon; Jin Chul Ahn; Sreemathi Logan; Albert Orock; Kyeung Min Joo; Andrea Lőrincz; Ferenc Deák
Journal:  Geroscience       Date:  2019-04-30       Impact factor: 7.713

2.  Gestational stress induces depressive-like and anxiety-like phenotypes through epigenetic regulation of BDNF expression in offspring hippocampus.

Authors:  Yu Zheng; Weidong Fan; Xianquan Zhang; Erbo Dong
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

3.  Antidepressant, antioxidant and neurotrophic properties of the standardized extract of Cocos nucifera husk fiber in mice.

Authors:  Eliane Brito Cortez Lima; Caren Nádia Soares de Sousa; Germana Silva Vasconcelos; Lucas Nascimento Meneses; Yuri Freitas E Silva Pereira; Naiara Coelho Ximenes; Manuel Alves Santos Júnior; Natália Castelo Branco Matos; Rayanne Brito; Diogo Miron; Luzia Kalyne Almeida Moreira Leal; Danielle Macêdo; Silvânia Maria Mendes Vasconcelos
Journal:  J Nat Med       Date:  2016-02-08       Impact factor: 2.343

4.  Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease.

Authors:  Fábio A Morais; Isabela S Lemos; Rafaela T Matiola; Maria Luísa S Freitas; Carolina G Alano; Julia Cabral; Leticia B Wessler; Jaqueline S Generoso; Giselli Scaini; Gislaine Z Réus; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2022-04-08       Impact factor: 3.584

5.  The Serum BDNF Level Offers Minimum Predictive Value for Motor Function Recovery After Stroke.

Authors:  Wenshu Luo; Tao Liu; Shanshan Li; Hongmei Wen; Fenghua Zhou; Ross Zafonte; Xun Luo; Minghzu Xu; Randie Black-Schaffer; Lisa J Wood; Yulong Wang; Qing Mei Wang
Journal:  Transl Stroke Res       Date:  2018-08-03       Impact factor: 6.829

6.  Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation.

Authors:  Zhaoxiang Ren; Pengju Yan; Liushuai Zhu; Huicui Yang; Yafei Zhao; Brian P Kirby; John L Waddington; Xuechu Zhen
Journal:  Psychopharmacology (Berl)       Date:  2017-10-20       Impact factor: 4.530

7.  Glycyrrhizic Acid Alleviates 6-Hydroxydopamine and Corticosterone-Induced Neurotoxicity in SH-SY5Y Cells Through Modulating Autophagy.

Authors:  Guangyi Yang; Jing Li; Youli Cai; Zhonghua Yang; Rong Li; Wenjun Fu
Journal:  Neurochem Res       Date:  2018-09-11       Impact factor: 3.996

8.  Relevance of Post-Stroke Circulating BDNF Levels as a Prognostic Biomarker of Stroke Outcome. Impact of rt-PA Treatment.

Authors:  Marion Rodier; Aurore Quirié; Anne Prigent-Tessier; Yannick Béjot; Agnès Jacquin; Claude Mossiat; Christine Marie; Philippe Garnier
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

9.  Antidepressant-Like Effects of Acupuncture-Insights From DNA Methylation and Histone Modifications of Brain-Derived Neurotrophic Factor.

Authors:  Huili Jiang; Xuhui Zhang; Jun Lu; Hong Meng; Yang Sun; Xinjing Yang; Bingcong Zhao; Tuya Bao
Journal:  Front Psychiatry       Date:  2018-03-27       Impact factor: 4.157

Review 10.  Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities.

Authors:  Wei Liu; Xiaohui Wang; Margaret O'Connor; Guan Wang; Fang Han
Journal:  Neural Plast       Date:  2020-01-27       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.